Tele: 561.316.3330
Breaking Medical Device News

Wednesday, September 22, 2021

HomeEXECUTIVESProf. Nir Uriel Appointed to Leviticus Cardio Scientific Advisory Board

Prof. Nir Uriel Appointed to Leviticus Cardio Scientific Advisory Board

“We are very excited that Prof. Uriel has joined our Scientific Advisory Board. He is a leader in the field of heart failure, mechanical circulatory support and heart transplantation, and he will help us greatly in promoting our wireless solution to the LVAD area,” said Michael Zilbershlag, CEO of Leviticus Cardio.

Prof. Uriel said, “This is indeed a great opportunity for me to take part in promoting the wireless solution for LVAD patients. Driveline infection remained one of the limiting problems of LVAD technology and a solution that will bring wireless LVAD to those patients will improve quality of life and longevity of advanced heart failure patients. I am convinced that it will help many patients around the world and I am proud to take part in promoting this technology coming from Israel.”

Leviticus FiVAD (Fully Implanted VAD) is wirelessly charged using an external belt along with an internal battery that has proven to last between six to eight hours between charges. Leviticus Cardio’s wireless power transfer technology, combined with any existing Ventricular Assist Device (VAD) system, provides a new, robust, comprehensive hybrid solution for Chronic Heart Failure (CHF) patients.

Prof. Uriel serves as the Louis Block Professor of Medicine; Director, Heart Failure, Transplant and Mechanical Circulatory Support at UChicago Medicine. Prof. Uriel specializes in caring for patients who require mechanical circulatory support, including ventricular assist devices (VADs) and is the immediate past Chair of the Mechanical Circulatory Support Council of the International Society of Heart and Lung Transplantation.

Prof. Uriel’s research focuses on advanced heart failure physiology, heart transplant and mechanical circulatory support. Prof. Uriel specialized and reported physiological changes and developed treatment algorithms for patients supported with mechanical circulatory support that are being used worldwide. These findings were published in the Journal of American College of Cardiology, Circulation and JHLT and more. He has a strong interest in high-risk transplant populations, including combined multi organ transplant, HIV-positive patients and patients who have received mediastinal radiation due to tumors or prior transplants. Through his research, Prof. Uriel has improved treatment protocols and patient care for these high-risk groups.

Prof. Uriel has published more than 200 original peer-reviewed articles. In addition, he serves as a reviewer for several scientific journals, including American Journal of Transplantation, Journal of American College of Cardiology and Journal of Heart and Lung Transplantation.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Kleiner Device Labs Receives FDA Market Clearance for KG2 Surge Flow-Thru Interbody System

The system maximizes total bone graft delivery volume, better distributes graft bilaterally into the intervertebral disc space, and streamlines the implant delivery, positioning, and grafting process for TLIF and PLIF spinal fusion procedures.

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

By using this website you agree to accept Medical Device News Magazine Privacy Policy